Elitek
Active Ingredient(s): RasburicaseFDA Approved: * July 12, 2002
Pharm Company: * SANOFI SYNTHELABO
Category: Cancer
Rasburicase (trade names Elitek in the US and Fasturtec in the EU) is a medication that helps to clear uric acid from the blood. It is a recombinant version of urate oxidase, an enzyme that metabolizes uric acid to allantoin. Urate oxidase is known to be present in many mammals but does not naturally occur in humans.[1] Rasburicase is produced by a genetically modified Saccharomyces cerevisiae strain. The complementary DNA (cDNA) coding for rasburicase was cloned from a strain... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.